---All---
  • ---All---
  • Accession
  • Catalog #

TACSTD2 predesign siRNASynthetic RNA

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
RI15204 5 OD 400 ul 13-15 days $ 110.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

TACSTD2 predesign siRNA - Additional info

Gene ID4070
Gene SymbolTACSTD2
Other Names
EGP1, GP50, M1S1, EGP-1, TROP2, GA7331, GA733-1, TACSTD2
Format
HPLC purified siRNA is supplied as a dried pellet in nmol quantities.
Storage
Maintain refrigerated at 2-8°C for up to one week. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This intronless gene encodes a carcinoma-associated antigen. This antigen is a cell surface receptor that transduces calcium signals. Mutations of this gene have been associated with gelatinous drop-like corneal dystrophy.

REFERENCES

Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma. Kobayashi H, et al. Virchows Arch, 2010 Jul. PMID 20473768. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Bignotti E, et al. Eur J Cancer, 2010 Mar. PMID 20060709. A novel TACSTD2 mutation identified in two Chinese brothers with gelatinous drop-like corneal dystrophy. Jing Y, et al. Mol Vis, 2009 Aug 14. PMID 19693293. [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance] Xu KY, et al. Zhonghua Wei Chang Wai Ke Za Zhi, 2009 May. PMID 19434540. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Fang YJ, et al. Int J Colorectal Dis, 2009 Aug. PMID 19421758.